Phathom Pharmaceuticals

Contributing Author

Recent Articles by Phathom Pharmaceuticals

Jun-06	Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032 PHAT GlobeNewswire
May-15	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences PHAT GlobeNewswire
May-01	Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PHAT GlobeNewswire